Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
dexmedetomidine (precedex) (1 trial)
doxorubicin (Doxil) (1 trial)
ihbg-10 (3 trials)
Octacosanol (1 trial)
sitagliptin (januvia) (1 trial)
everolimus (zortress) (1 trial)
niraparib (zejula) (1 trial)
paclitaxel (taxol) (1 trial)
sapanisertib (1 trial)
tak-117 (1 trial)
vitamin d3 (1 trial)
Breast Neoplasms (Phase 2)
Cardiotoxicity (Phase 2)
Hyperlipidemias (Phase 1)
Myalgia (Phase 1)
Neoplasms (Phase 1)
Obesity (Phase 2)
Weight Loss (Phase 2)
Trials (9 total)
Trial APIs (11 total)